Skip to main content

Lexapro

NDC 0456-2020 · Allergan, Inc.

Generic nameESCITALOPRAM
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)ESCITALOPRAM OXALATE
Strength20 mg/1
Pharmacologic classSerotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
Marketing categoryNDA

Packages

0456-2020-01 — 100 TABLET, FILM COATED in 1 BOTTLE (0456-2020-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0456-2005 — ESCITALOPRAM, 0456-2010 — ESCITALOPRAM, 0615-8475 — Escitalopram Oxalate, 0615-8476 — Escitalopram Oxalate, 0615-8477 — Escitalopram Oxalate, 0904-6426 — escitalopram, 0904-6427 — escitalopram, 13668-135 — escitalopram, 13668-136 — escitalopram, 13668-137 — escitalopram, 16571-755 — escitalopram, 16571-756 — escitalopram, 16571-757 — escitalopram, 16571-769 — Escitalopram Oxalate, 16729-168 — Escitalopram, 16729-169 — Escitalopram, 16729-170 — Escitalopram, 31722-569 — Escitalopram Oxalate, 33342-036 — Escitalopram Oxalate, 33342-037 — Escitalopram Oxalate, +133 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels